Medications for PSP Symptoms

Medications for PSP Symptoms

PSP, or progressive supranuclear palsy, is a rare neurodegenerative disorder that affects movement, balance, and cognition. Unfortunately, there is currently no cure for PSP, and the available treatments only aim to manage symptoms and improve quality of life.

The medications used for PSP typically target the specific symptoms of the disease. Here are some examples:

  1. Levodopa: This medication is commonly used to treat Parkinson's disease, another neurodegenerative disorder that shares some similarities with PSP. Levodopa can help improve movement and reduce stiffness and rigidity in PSP patients.
  2. Myrbetriq (mirabegron) is a medication used to treat overactive bladder, which is a condition where the bladder muscles contract involuntarily, causing a sudden and urgent need to urinate.
  3. Antidepressants: Some types of antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), can help alleviate depression, anxiety, and other mood disorders that often accompany PSP.
  4. Muscle relaxants: These medications, such as baclofen or tizanidine, can help reduce muscle stiffness and spasticity, which are common symptoms of PSP.
  5. Speech and language therapy: While not a medication, speech and language therapy can be an effective treatment for the speech and swallowing difficulties that often occur in PSP patients.

It's important to note that each PSP patient is unique, and the specific medications and treatments used may vary depending on individual symptoms and needs. Treatment should be tailored to the individual patient by a qualified healthcare professional.

Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • 🥯 Bagel Fundraiser

    🥯 Bagel Fundraiser

    JOIN THE COLEEN CUNNINGHAM FOUNDATION 🥯 Bagel Fundraiser FOR THE BENEFIT OF THOSE WITHAtypical Parkinson Diseases NOVEMBER 2ND • 11-1 PM AT THE ROCKVILLE JCC IN PARTNERSHIP WITH BETHESDA BAGELS

    🥯 Bagel Fundraiser

    JOIN THE COLEEN CUNNINGHAM FOUNDATION 🥯 Bagel Fundraiser FOR THE BENEFIT OF THOSE WITHAtypical Parkinson Diseases NOVEMBER 2ND • 11-1 PM AT THE ROCKVILLE JCC IN PARTNERSHIP WITH BETHESDA BAGELS

  • HOPE by Bhavna

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

  • Active Neurodegenerative Disease Clinical Trials (PSP, MSA, DLB, CBS, Parkinsonian Syndromes)

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    1 comment

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    1 comment
  • Recruiting participants for a groundbreaking study: “Assessing Cognitive Trajectories in Progressive Supranuclear Palsy Using Remote Computerized Reaction Time Tasks.”

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

1 of 4